Keyphrases
Immune Checkpoint Inhibitors
84%
Kidney Transplant Recipients
60%
Kidney Transplant
57%
Transplantation
35%
Kidney Transplantation
35%
Immune Regulation
34%
Alloimmunization
32%
T Cells
31%
COVID-19
28%
Transplant Oncology
28%
Immunosuppression
26%
Transplant Recipients
24%
Immune-related Adverse Events
23%
Clinical Outcomes
22%
Acute Kidney Injury
22%
Dairy-free Diet
21%
Gluten-free
21%
Onconephrology
21%
Treg
20%
In Cancer
20%
Kidney
19%
Cancer Treatment
19%
Confidence Interval
19%
Programmed Death-ligand 1 (PD-L1)
19%
Pretransplant
18%
Donor-specific Antibodies
17%
Kidney Transplant Rejection
17%
Face Transplant
17%
Immune Checkpoint Inhibitor Therapy
16%
Palliative Care
16%
Kidney Disease
16%
Allograft
15%
B Cells
15%
Transplant Rejection
15%
Antibody-mediated Rejection
15%
Antithymocyte Globulin
14%
Meta-analysis
14%
Systematic Meta-analysis
14%
Therapeutic Advances
14%
Immune Checkpoint
14%
Malignancy
14%
Nephrologists
13%
Acute Rejection
13%
Myeloma
13%
Lysophosphatidylcholine
13%
Cancer Screening
13%
Transplant Patients
13%
Steroid-resistant Nephrotic Syndrome
12%
Proteinuria
12%
Patient Survival
12%
Medicine and Dentistry
Transplantation
100%
Kidney Graft
94%
Immune Checkpoint Inhibitor
79%
Allograft
36%
Malignant Neoplasm
34%
Kidney Transplantation
32%
Oncology
28%
T Cell
28%
Immunity
25%
Immunosuppressive Treatment
25%
Immune-Related Adverse Events
23%
Acute Graft Rejection
22%
Cancer
21%
COVID-19
21%
Biopsy Technique
20%
Nephropathy
17%
Diseases
16%
Clinician
16%
Immunoregulation
16%
Kidney Allograft
15%
Proteinuria
15%
Alloimmunity
15%
Immunotherapy
15%
Interstitial Nephritis
15%
Nephrology
15%
Kidney Function
15%
Symptomatic Treatment
15%
Thymocyte Antibody
14%
Face Transplant
14%
Congenital Nephrotic Syndrome
14%
Systematic Review
14%
Low Drug Dose
14%
Meta-Analysis
14%
Cancer Therapy
13%
End Stage Renal Disease
12%
Acute Kidney Injury
12%
Antibodies
12%
Antiviral Drug
11%
Pathophysiology
11%
Cancer Treatment
11%
Calcineurin Inhibitor
11%
Nephrologist
10%
Adverse Event
10%
Immune Checkpoint Blockade
10%
Nivolumab
10%
Hepatocellular Carcinoma
10%
Graft Rejection
10%
Cancer Screening
9%
Graft Survival
9%
B Cell
9%
Immunology and Microbiology
Immunity
56%
Alloimmunity
37%
T Cell
33%
Immunoregulation
33%
Allograft
28%
Regulatory T Cell
24%
Kidney Transplantation
23%
Antibodies
22%
Immunosuppression
22%
Face
21%
Transplant Rejection
20%
Acute Graft Rejection
15%
Infectious Agent
15%
Antibody Mediated Rejection
15%
Anti-Thymocyte Globulin
14%
Low Drug Dose
14%
Autoimmunity
14%
Immune Response
13%
B Cell
12%
Notch
11%
Squamous Cell
10%
Kidney Graft Rejection
9%
Leukocyte
9%
Humoral Immunity
9%
Dendritic Cell
9%
Tacrolimus
9%
interferon
9%
Alloreactive T Cell
8%
T Cell Receptor
8%
Follicular B Helper T Cells
8%
Interleukin 2
8%
Multiple Myeloma
7%
Pathogenicity
7%
Notch Signaling
7%
Kidney Function
7%
Amyloidosis
7%
Human Leukocyte Antigen
7%
Cell Expansion
7%
Macrophage
7%
Multi-Omics
7%
Leukotriene B4
7%
Allele
7%
COVID-19
7%
Dynamics
7%
T Helper Cell
7%
T Cell Depletion
7%
Plasma Cell Dyscrasia
7%
Glycoprotein
7%
Codominance
7%
Immune System
7%